Assessing Exclusive Breastfeeding Practice

March 30, 2024 updated by: Pattanee Winichagoon, Mahidol University

Validation of Maternal Recall of Exclusive Breastfeeding by the Deuterium Dilution Method: a Study in 7 Asian Countries

This study was a longitudinal design. The questionnaire on exclusive breastfeeding was administered and was validated against the deuterium oxide dose-to-mother technique to assess human milk intake of babies aged 3 and 6 mo.

Study Overview

Detailed Description

This study is a longitudinal design that aimed to assess exclusive breastfeeding (EBF) practices in Asian countries and to compare the agreement in EBF between maternal recall and the dose-to-mother technique (DTM) technique. The questionnaire on exclusive breastfeeding was administered and was validated against the deuterium oxide dose-to-mother technique to assess human milk intake of babies aged 3 and 6 mo. The study planned to recruit 30 mother-baby pairs from each participated country. The was carried out in 7 countries in Asia, namely, Indonesia, Malaysia, Mongolia, Pakistan, Sri Lanka, Thailand, and Vietnam.

Mothers were approached at child birth, to explain the project objective and obtain written informed consent. A screening questionnaire was administered to obtain the interest to participate in the study. Only mothers who intend to exclusive breastfeeding till 6 mo will be eligible for further information and sample collection. Isotope dosing of mothers and saliva sample collection were done when the baby is at 3 mo ± 1wk, when a questionnaire (validation questionnaire) was administered. A basal saliva sample was collected prior to dosing with deuterium oxide. The isotope dosing of the mother was given and saliva samples were collected (post-dose) on day 1,2,3,4 and days 13,14.

The mother-baby pairs were followed up for another sample collection at 6 mo ± 1 wk and all procedures were repeated, including a questionnaire administration, basal sample collection, deuterium oxide dose administration, and post-dose sample collection. Body weight and height/length of mothers and infants were measured. All saliva samples were analyzed by Isotope ratio mass spectrometer (IRMS) or Fourier Transform Infrared Spectroscopy (FTIR).

Quantity of breast milk intake, non milk oral intake (NMOI) and maternal body composition were determined using standard assumption and formulae developed by the International Atomic Energy Agency (IAEA). Children with NMOI ≥ 86.6 g/day were considered as non-EBF using stable isotopic DTM technique. The overall agreement of EBF classification between the recall and DTM techniques is presented using Kappa statistic with 95% confidence interval.

Study Type

Observational

Enrollment (Actual)

206

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The participants were mother-baby pairs who were eligible according to the inclusion and exclusion criteria. There were recruited from hospitals, health clinics, or communities.

Description

Inclusion Criteria:

  • Mother who practice exclusive breastfeeding
  • Age of mother 18 - 40 years
  • Parity: no more than 3
  • Baby 3 month ± 7 days
  • Nutritional status Weight-for-height Z score (WHZ) > -2
  • Full term baby (37 - 40 weeks)

Exclusion Criteria:

  • Twin or more baby
  • Low birth weight
  • Baby with oedema
  • Mother with fluid retention disease (kidney disease, heart disease, hypothyroidism)
  • Smoking mother
  • Drinking alcohol mother

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
This is an observation study to determine exclusive breastfeeding practice. Mother-child pairs were enrolled at 3 months ± 7d and were followed-up at 6 months ± 7d. Questionnaire was administered. Then, baseline saliva samples were collected and deuterium oxide dose was administered. Then, post-dose saliva samples were collected.
Exclusive breastfeeding practice was compared between maternal recall and the deuterium dose-to-mother method.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non-milk oral intake
Time Frame: Jan 2016 - Dec 2020
Quantity of non-milk oral intake (g)
Jan 2016 - Dec 2020
Human milk intake
Time Frame: Jan 2016 - Dec 2020
Quantity of milk intake (g)
Jan 2016 - Dec 2020

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition of mothers: total body water
Time Frame: Jan 2016 - Dec 2020
Total body water in kilograms and as a percentage of body weight
Jan 2016 - Dec 2020
Body composition of mothers: fat free mass
Time Frame: Jan 2016 - Dec 2020
Fat free mass in kilograms and as a percentage of body weight
Jan 2016 - Dec 2020
Weight of infants
Time Frame: Jan 2016 - Dec 2020
Body weight in kilograms
Jan 2016 - Dec 2020
Weight of mothers
Time Frame: Jan 2016 - Dec 2020
Body weight in kilograms
Jan 2016 - Dec 2020
Height of mothers
Time Frame: Jan 2016 - Dec 2020
Height in centimeters. The body mass index (BMI) was calculated by dividing weight in kilograms by height in meters squared.
Jan 2016 - Dec 2020
Body mass index of mothers
Time Frame: Jan 2016 - Dec 2020
weight in kilograms divided by height in meters squared
Jan 2016 - Dec 2020
Breastfeeding pattern
Time Frame: Jan 2016 - Dec 2020
Breastfeeding pattern based on questionnaire
Jan 2016 - Dec 2020
Body composition of mothers: fat mass
Time Frame: Jan 2016 - Dec 2020
Fat mass in kilograms and as a percentage of body weight
Jan 2016 - Dec 2020
length of infants
Time Frame: Jan 2016 - Dec 2020
Body length in centimeters. Weight-for-age, length-for-age, and weight-for-length z-scores were calculated based on the World Health Organization (WHO) growth standard.
Jan 2016 - Dec 2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

January 1, 2020

Study Registration Dates

First Submitted

July 16, 2023

First Submitted That Met QC Criteria

July 23, 2023

First Posted (Actual)

July 25, 2023

Study Record Updates

Last Update Posted (Actual)

April 2, 2024

Last Update Submitted That Met QC Criteria

March 30, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RAS6073

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Human Milk

Clinical Trials on Deuterium dose-to-mother method for assessing breastfeeding

3
Subscribe